Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-19T06:12:48.294Z Has data issue: false hasContentIssue false

37 - Dystonia

from PART III - DISORDERS OF MOTOR CONTROL

Published online by Cambridge University Press:  05 August 2016

Barbara Illowsky Karp
Affiliation:
Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA
Susanne Goldstein
Affiliation:
Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA
Mark Hallett
Affiliation:
Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA
Arthur K. Asbury
Affiliation:
University of Pennsylvania School of Medicine
Guy M. McKhann
Affiliation:
The Johns Hopkins University School of Medicine
W. Ian McDonald
Affiliation:
University College London
Peter J. Goadsby
Affiliation:
University College London
Justin C. McArthur
Affiliation:
The Johns Hopkins University School of Medicine
Get access

Summary

Dystonia is a movement disorder characterized by sustained involuntary muscle contraction causing abnormal twisting, repetitive movements or posturing that tend to have a directional predominance.Descriptions of dystonic patients, who were often believed to be hysterical, first appeared at the beginning of the twentieth century (Zeman & Dyken, 1968). In 1908, Schwalbe ascertained the hereditary nature of the illness and its variable expression (Schwalbe, 1908). The term‘dystonia musculorum deformans’ was first used by Oppenheim (1911), while Mendel and Flateau, emphasizing the twisted posture, called the disease ‘torsion dystonia’ or ‘torsion spasm’ (Flateau & Sterling, 1911; Zeman & Dyken, 1968).

After a period of relative inattention, interest in dystonia revived in the 1970s with a fuller delineation of the symptomatology allowing the recognition of focal forms. More recent technological developments have culminated in the identification of genetic mutations underlying generalized torsion dystonia, dopa-responsive dystonia, and some focal dystonias. New therapies have been developed including botulinum toxin injections, stereotactic surgery, and deep brain stimulation.

Classification

Dystonia can be classified by etiology, by the body area involved, and by the age of onset. The division by etiology into primary (idiopathic) and secondary (symptomatic) dystonia provides a schema for evaluating the patient. The classification by affected region is especially useful for the primary dystonias, where the epidemiology, prognosis, treatment and genetics differ by dystonia type. Classifying dystonia by age of onset is also most applicable to primary dystonia, where it serves to separate idiopathic generalized torsion dystonia of childhood onset from the focal dystonias which typically present in adulthood.

A classification suggested by Fahn et al., divides dystonias into primary dystonia, ‘dystonia-plus’ syndromes in which dystonia combines with other neurological symptomatology, secondary dystonia where an underlying pathological process causing dystonia can be identified, and heredofamilial dystonia in which there is an underlying neurodegenerative disorder (Fahn et al., 1998).

Signs and symptoms

Idiopathic dystonia often first manifests as a feeling of discomfort or stiffness in the affected body part. Abnormal movement ensues and initially may only be apparent when performing specific acts, interfering with smooth and accurate performance. As it progresses, dystonia occurs with other voluntary movements and may eventually be present even at rest. Dystonic muscles may hypertrophy; fixed contractures and deformity occur in severe cases. Dystonia disappears during sleep.

Type
Chapter
Information
Diseases of the Nervous System
Clinical Neuroscience and Therapeutic Principles
, pp. 532 - 550
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Dystonia
    • By Barbara Illowsky Karp, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA, Susanne Goldstein, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA, Mark Hallett, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA
  • Edited by Arthur K. Asbury, University of Pennsylvania School of Medicine, Guy M. McKhann, The Johns Hopkins University School of Medicine, W. Ian McDonald, University College London, Peter J. Goadsby, University College London, Justin C. McArthur, The Johns Hopkins University School of Medicine
  • Book: Diseases of the Nervous System
  • Online publication: 05 August 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781316134993.038
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Dystonia
    • By Barbara Illowsky Karp, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA, Susanne Goldstein, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA, Mark Hallett, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA
  • Edited by Arthur K. Asbury, University of Pennsylvania School of Medicine, Guy M. McKhann, The Johns Hopkins University School of Medicine, W. Ian McDonald, University College London, Peter J. Goadsby, University College London, Justin C. McArthur, The Johns Hopkins University School of Medicine
  • Book: Diseases of the Nervous System
  • Online publication: 05 August 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781316134993.038
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Dystonia
    • By Barbara Illowsky Karp, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA, Susanne Goldstein, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA, Mark Hallett, Office of the Clinical Director and Human Motor Control Section NINDS, NIH, Bethesda, Maryland, USA
  • Edited by Arthur K. Asbury, University of Pennsylvania School of Medicine, Guy M. McKhann, The Johns Hopkins University School of Medicine, W. Ian McDonald, University College London, Peter J. Goadsby, University College London, Justin C. McArthur, The Johns Hopkins University School of Medicine
  • Book: Diseases of the Nervous System
  • Online publication: 05 August 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781316134993.038
Available formats
×